Sientra logo
Sientra SIEN

Quarterly report 2023-Q3
added 11-13-2023

report update icon

Sientra Income Statement 2011-2026 | SIEN

Annual Income Statement Sientra

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

171 M 236 M 254 M 280 M 229 M 155 M 134 M 38.3 M - - -

Shares

57.1 M 50.2 M 40.7 M 25.4 M 19.2 M 18.2 M 15.8 M 2.55 M - - -

Historical Prices

3.67 3.89 8.94 12.7 14.1 8.52 5.92 16.8 - - -

Net Income

-62.5 M -89.9 M -107 M -82.6 M -64 M -40.2 M -41.2 M -5.81 M -19.1 M -23.4 M -

Revenue

80.7 M 71.2 M 83.7 M 68.1 M 36.5 M 20.7 M 38.1 M 44.7 M 35.2 M 10.4 M -

Cost of Revenue

36.3 M 23.6 M 16.4 M 26.8 M 14.2 M 6.88 M - - - - -

Gross Profit

44.3 M 38.9 M 50.7 M 41.3 M 22.4 M 13.9 M 27.5 M 33.2 M 26.6 M 8.1 M -

Operating Income

-46.4 M -47.4 M -54.9 M -79.8 M -62.9 M -40 M -38.5 M -5.78 M -18.2 M -23.4 M -

Interest Expense

8.25 M 9.44 M 4.57 M 3.43 M 1.23 M 98 K 3.1 M 2.17 M 872 K -1 K -

EBITDA

-42 M -58 M -86.3 M -76.5 M -59.9 M -38.9 M -23.9 M -5.51 M -17.9 M -23.1 M -

Operating Expenses

90.7 M 101 M 140 M 121 M 85.3 M 53.9 M 51.7 M 39 M 44.8 M 31.5 M -

General and Administrative Expenses

31.8 M 38.2 M 46.8 M 42.4 M 41.5 M 23.6 M 18.7 M 10.7 M 18.1 M 9.94 M -

All numbers in USD currency

Quarterly Income Statement Sientra

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

11.3 M 11.2 M - 10.7 M 6.28 M 6.26 M 62.3 M 62.2 M 58 M 57.6 M 54.3 M 50.6 M 50.4 M 50.1 M 49.9 M 49.5 M 49.4 M 34.3 M 29.1 M 28.6 M 28.5 M 24.8 M 19.6 M 19.4 M 19.3 M 19.1 M 18.8 M 18.6 M 18.2 M 18.1 M 18.1 M 18 M 15.2 M 14.9 M 14.9 M 14.9 M 209 K 209 K 208 K 207 K 206 K - - - - - - - - - -

Net Income

-14.8 M -9.48 M -12.9 M - -15 M -18.3 M -18 M - 28.4 M -20.1 M -54.7 M -21.2 M -5.82 M -34.3 M -28.6 M -20.2 M -22.4 M -37.7 M -26.5 M -24.6 M -20.5 M -18 M -19.4 M -17.8 M -14.4 M -20.4 M -11.4 M -8.07 M -9.96 M -10.2 M -11.9 M -28.2 M -6.6 M -2.99 M -3.38 M -3.2 M -1.45 M -160 K -1 M -3.08 M -6.48 M -5.46 M -4.11 M - - - - - - - -

Revenue

19.5 M 23.1 M - - 22.6 M 21.5 M 21.4 M - 19.6 M 20.1 M 18.3 M 22.6 M 15.3 M 9.31 M 16.9 M 23.2 M 22.4 M 20.5 M 17.6 M 19 M 16.9 M 17.6 M 14.7 M 11.1 M 9.82 M 8.17 M 7.49 M - 6.53 M - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

9.52 M 10.5 M - - 9.79 M 8.77 M 8.55 M - 9.03 M 8.84 M 8.16 M - 7.1 M 4.05 M 6.79 M - 9.75 M 7.81 M 6.47 M - 6.4 M 6.66 M 6.1 M - 3.48 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

10 M 12.6 M - - 12.8 M 12.7 M 12.8 M - 10.6 M 11.3 M 10.2 M 11.1 M 8.22 M 5.26 M 10.1 M 14.2 M 12.7 M 12.7 M 11.1 M 11.4 M 10.5 M 10.9 M 8.58 M 5.32 M 6.34 M 5.55 M 5.17 M 3.93 M 4.72 M 4.5 M 711 K 990 K 7 M 10.3 M 9.2 M 8.9 M 7.84 M 8.84 M 7.65 M 7.01 M 6.01 M 7.07 M 6.49 M - - - - - - - -

Operating Income

-9.4 M -7.11 M - - -12.6 M -15.9 M -16.1 M - -11.7 M -9.16 M -11.8 M - -9.53 M -9.24 M -27 M - -21.5 M -37 M -25.9 M - -19.6 M -16.9 M -18.9 M - -13.9 M -20.2 M -11.4 M - -9.77 M -10.2 M -11.9 M - -5.57 M -2.12 M -2.63 M - -753 K -1.2 M -1.38 M - -6.23 M - - - - - - - - - -

Interest Expense

2.37 M 2.51 M - - 2.36 M 2.32 M 1.9 M - 2.03 M 2.11 M 2 M - 2.06 M 3.61 M 1.62 M - 1.34 M 982 K 952 K - 953 K 867 K 655 K - 409 K 185 K 9 K - 105 K 12 K 1 K - 1.61 M 671 K 668 K - 665 K 411 K 431 K - 232 K - - - - - - - - - -

EBITDA

-8.5 M -6.21 M - - -12 M -15.2 M -14.4 M - -8.54 M -7.05 M -10.7 M - -7.14 M -8.04 M -25.8 M - -18.9 M -35.2 M -25 M - -17.1 M -15.2 M -18 M - -11.8 M -19.1 M -10.8 M - -9.04 M -9.78 M -11.8 M - -5.34 M -1.97 M -2.55 M - -557 K -1.08 M -1.32 M - -6.02 M - - - - - - - - - -

Operating Expenses

19.4 M 19.7 M - - 25.3 M 28.7 M 28.9 M - 22.3 M 20.4 M 21.9 M - 17.8 M 14.5 M 37.1 M - 34.1 M 49.7 M 36.9 M - 30 M 27.8 M 27.5 M - 20.2 M 25.8 M 16.6 M - 14.5 M 14.7 M 12.6 M - 12.6 M 12.4 M 11.8 M - 8.59 M 10 M 9.03 M - 12.2 M - - - - - - - - - -

General and Administrative Expenses

7.62 M 7.33 M - - 9.32 M 12.1 M 10.2 M - 7.86 M 7.54 M 7.91 M - 6.44 M 6.94 M 9.3 M - 12.2 M 11.8 M 13.5 M - 11.9 M 10 M 9.5 M - 9.3 M 8.02 M 6.44 M - 5.68 M 5.36 M 5.29 M - 4.14 M 3.94 M 3.72 M - 2.63 M 2.64 M 2.27 M - 6.3 M - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Sientra (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Aethlon Medical Aethlon Medical
AEMD
$ 2.11 8.21 % $ 3.29 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 10.42 -1.65 % $ 1.41 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Alphatec Holdings Alphatec Holdings
ATEC
$ 12.6 2.61 % $ 1.89 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 3.91 2.62 % $ 828 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.38 -0.24 % $ 602 M israelIsrael
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 69.79 0.95 % $ 103 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.96 1.02 % $ 148 M franceFrance
CONMED Corporation CONMED Corporation
CNMD
$ 37.41 0.35 % $ 1.16 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.65 -8.13 % $ 35.4 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.03 2.22 % $ 298 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 63.48 0.21 % $ 1.88 B costa-ricaCosta-rica
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
FONAR Corporation FONAR Corporation
FONR
$ 18.42 0.22 % $ 121 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 13.43 -0.81 % $ 868 M israelIsrael
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 109.95 1.8 % $ 191 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.81 3.81 % $ 351 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 261.24 -0.59 % $ 7.37 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.19 3.79 % $ 1.33 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.01 -2.49 % $ 694 M usaUSA
AxoGen AxoGen
AXGN
$ 32.84 1.55 % $ 1.51 B usaUSA
Align Technology Align Technology
ALGN
$ 169.45 3.18 % $ 12.7 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 32.76 -2.93 % $ 4.88 K usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.33 2.31 % $ 21.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.67 1.1 % $ 151 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 17.11 -1.16 % $ 401 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 84.12 1.34 % $ 2.92 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA